Please activate JavaScript!
Please install Adobe Flash Player, click here for download
ePaper created 2015-07-06, 08:54:49 | version 1.39.0
HematologyHematology Breaking new ground in haemostasis, urinalysis, cancer management, essential healthcare, life sciences, near patient testing and automation. The Sysmex Corporation The global leader in hematology. F ounded in 1968, The Sysmex Corporation has challenged its way past far larger companies to become one of the leading healthcare companies around the world. How? By focusing constantly on one objective: maximising the strength of our people, knowledge and resourcefulness to live up to our mission statement: Shaping the Advancement of Healthcare. Healthier and more enjoyable Nobody within Sysmex will claim that we have or will have the answer to all of healthcare's problems. You will hear us say, howe- ver, that we deliver true solutions to real problems. And that, by focusing our knowledge on the issues you face as our customers - on what you need and not just on what we can do - we make your wor- king lives more effective, more efficient, and therefore hopefully more rewarding. If it falls in our domain of expertise, you can count on us to try and solve your challenge. Just ask. Focus focus focus Ð for you We are quite simply very good at what we do. From the start our focus has been on hematology. And here we are the global leaders. With the introduction of our XN-Series in 2011, we set new benchmarks in the industry, and we have by no means yet exhaus- ted the clinical potential of these remarkable analysers. Their accuracy, associated services and consultancy, and their ease of use remain unmatched. We are excited about what is yet to come. Importantly, we have very recently expanded the XN family to include three new analysers for labs with less large-scale needs Ð the XN-L series. Now the quality and clinical significance available on the larger XN is within reach of almost all labs. But Business 101 tells you that once you have achieved significant market penetration, growth potential is limited. In addition to our two other core areas Ð haemostasis and urinalysis Ð we therefore started expanding our areas of expertise some time ago. We have already developed important solutions in life sciences, cancer management and near patient testing and are now entering new areas where we know we will make a difference for you. Two acquisitions, and the exclusive distributorship of a revolutionary Intelligent Lab Automation solution are opening new doors. Sysmex Partec Ð flow cytometry pioneers Partec brought to market the first fluorescence-based and commer- cial flow cytometer (FCM). By combining the latest scientific and LABBOOK 201530 LABBOOK 2015